Clin2
NCT07313722Possibly a fitRecruiting

Testing a new eye drop for safety in healthy volunteers

Healthy

Treatments studied

This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
32 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • Be between 18 and 50 years old.
  • Have a healthy body weight (BMI between 18 and 27).
  • Have good vision (corrected to 20/25 or better) and normal eye pressure.
  • Not use contact lenses or have any ongoing eye disease or injury.
  • Be willing to avoid certain medications and alcohol during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07245017Recruiting· Early Phase 1
Testing JN002 drops for dry eye disease

This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.

Shanghai
NCT07370584Recruiting· Phase 1
Safety study of IVMED-85 eye drops in healthy adults

This phase 1 trial tests the safety of an investigational eye drop called IVMED-85 in healthy adults aged 18-49. Participants will receive the eye drops and be monitored for any side effects over 6 weeks.

Memphis, Tennessee
NCT06379685Not yet recruiting· Phase 1
Testing new eye drops for safety and comfort

This study tests a new eye drop (PRO-190) against a common artificial tear (Systane Ultra) to see how safe and comfortable it is. Healthy volunteers will use the drops and be monitored for any side effects or changes in their eyes.

NCT07764965Not yet recruiting· Phase 1
Eye drop safety study in healthy adults

This study tests a new eye drop medicine to see if it is safe and how the body handles it. It is for healthy adults only, not for treating a condition.

NCT06375343Not yet recruiting· Phase 1
Testing a new artificial tear versus Optive in healthy adults

This trial tests a new eye drop called PRO-240 versus Optive artificial tears in healthy adults. You will attend several visits over a few weeks and use the assigned drops as directed. The goal is to see if the new drop is as safe and comfortable as the standard one.

NCT06985875Not yet recruiting· Phase 3
Testing a new eye drop for dry eye relief

This trial tests a new eye drop, Drop 0.4%, for people with dry eye. It includes both people who wear contact lenses and those who don’t, to see if the drop is safe and helps with symptoms.

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.